2081 related articles for article (PubMed ID: 16890600)
1. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
4. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
5. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
7. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
8. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
Takayasu K; Arii S; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M
J Hepatol; 2012 Apr; 56(4):886-92. PubMed ID: 22173160
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
Lu W; Li Y; He X; Chen Y
Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
[TBL] [Abstract][Full Text] [Related]
13. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
15. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
16. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
